The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
4.690
-0.020 (-0.42%)
At close: May 29, 2026, 4:00 PM EDT
4.600
-0.090 (-1.92%)
After-hours: May 29, 2026, 7:46 PM EDT
The Oncology Institute Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, The Oncology Institute stock has a consensus rating of "Strong Buy" and an average price target of $7.00. The average 1-year stock price forecast is 49.25% higher than the current stock price, while the lowest is $5.00 (+6.61%) and the highest is $8.00 (+70.58%).
Price Target: $7.00 (+49.25%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for The Oncology Institute stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Noble Financial | Noble Financial | Buy Reiterates $8 | Buy | Reiterates | $8 | +70.58% | May 8, 2026 |
| Needham | Needham | Buy Reiterates $5 | Buy | Reiterates | $5 | +6.61% | May 8, 2026 |
| BTIG | BTIG | Buy Maintains $7 | Buy | Maintains | $7 | +49.25% | May 8, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $6 → $8 | Buy | Reiterates | $6 → $8 | +70.58% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
663.85M
from 502.73M
Increased by 32.05%
Revenue Next Year
828.28M
from 663.85M
Increased by 24.77%
EPS This Year
-0.20
from -0.54
EPS Next Year
-0.10
from -0.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 714.5M | 910.9M |
| Avg | 663.9M | 828.3M |
| Low | 630.7M | 761.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 42.1% | 37.2% |
| Avg | 32.0% | 24.8% |
| Low | 25.5% | 14.7% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.17 | -0.08 |
| Avg | -0.20 | -0.10 |
| Low | -0.26 | -0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.